Trial intelligence / Profile preview

Evaluation of antioxidant effects of NAC and vitamin B6 versus NAC and placebo in chemical warfare victims with chronic pulmonary lesions

IRCT20080901001165N54Phase 3Completed

Sponsor
Baqiyatallah University of Medical Sciences
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Pulmonary disease due to chemical warfare agents and Pulmonary lesion comparing N-acetylcysteine + vitamin B6 with N-acetylcysteine + placebo (2 arms). Primary endpoint: Antioxidant effect. Started Nov 2019; status: completed.

02

Drugs

acetylcysteinepyridoxine
03

Conditions

Pulmonary disease due to chemical warfare agentsPulmonary lesion

Beyond the preview

Go deeper on IRCT20080901001165N54.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20080901001165N54.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call